期刊
CLINICAL NUTRITION
卷 31, 期 2, 页码 217-223出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.clnu.2011.10.001
关键词
Omega-3 polyunsaturated fatty acids; Parenteral nutrition-associated liver disease; Short bowel syndrome; Cholestasis
资金
- National Natural Science Foundation of China [81072438]
Background & aims: Parenteral nutrition-associated liver disease (PNALD) complicates the treatment of patients with short bowel syndrome (SBS). Some studies have shown omega-3 polyunsaturated fatty acids (omega-3 PUFAs) have favorable effects in treating PNALD in children. We, therefore, investigate the effects of omega-3 PUFAs supplemented intravenous lipid emulsion (ILE) on PNALD in adults. Methods: We performed an open-labeled study of a omega-3 PUFAs based ILE in 15 adults with SBS who developed cholestasis while receiving soybean oil-based ILE. Liver biopsies were performed before and after the initiation of omega-3 PUFAs to confirm the presence and improvement of cholestasis. Blood samples were collected every week for analysis of fatty acid composition and liver function. Results: 12 of the 15 patients had their direct bilirubin normalized within 4 weeks and our data demonstrated a significant decrease in both DB (P <= 0.001) and TB (P <= 0.001) after 4 weeks compared to baseline. There were ameliorations of liver function and fatty acid patterns in all patients and serial liver biopsy specimens showed progressive histologic improvement. Conclusions: Parenteral PUFAs supplemented fat emulsions are safe and effective in the treatment of PNALD in adults. (C) 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据